imipramine has been researched along with clorgyline in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (31.71) | 18.7374 |
| 1990's | 8 (19.51) | 18.2507 |
| 2000's | 3 (7.32) | 29.6817 |
| 2010's | 16 (39.02) | 24.3611 |
| 2020's | 1 (2.44) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Lokanatha Rai, KM; Prashanth, MK; Revanasiddappa, HD; Veeresh, B | 1 |
| Alam, MM; Alex, AT; Bansal, S; Chaudhary, A; Jaiswal, V; Joseph, A; Suthar, SK; Tiwari, A | 1 |
| Deng, Y; Li, Y; Luo, L; Qiang, X; Tan, Z; Xiao, G | 1 |
| Alencar, N; Di Pietro, O; Esteban, G; Juárez-Jiménez, J; Luque, FJ; Muñoz-Torrero, D; Pérez, B; Sola, I; Solé, M; Szałaj, N; Unzeta, M; Vázquez, J; Viayna, E | 1 |
| Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Sang, Z; Su, F; Xiao, G; Yang, X; Zheng, Y | 1 |
| Ai, J; Deng, Y; Li, Y; Liu, Q; Luo, L; Qiang, X; Tan, Z; Xiao, G; Yang, X | 1 |
| Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Sang, Z; Su, F; Xiao, G; Xu, R; Yang, X; Zheng, Y | 1 |
| Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Tan, Z; Xu, R; Yang, X; Zheng, Y | 1 |
| Cao, Z; Deng, Y; Li, Y; Luo, L; Qiang, X; Song, Q; Tan, Z; Xiao, G; Xu, R; Yang, X | 1 |
| Liu, W; Ma, Q; Pan, W; Sang, Z; Wang, K; Yu, L | 1 |
| Han, X; Liu, W; Ma, Q; Sang, Z; Wang, H; Wang, K; Ye, M; Yu, L | 1 |
| Cao, Z; Deng, Y; Li, Y; Liu, H; Qiang, X; Song, Q; Tan, Z; Xu, R; Yang, J; Zhang, X | 1 |
| Deng, Y; Li, Y; Liu, H; Song, Q; Tan, Z; Xiao, G; Xu, R; Yang, Z; Zhang, X; Zheng, Y | 1 |
| Alcaro, S; Bagetta, D; Borges, F; Cagide, F; Oliveira, PJ; Ortuso, F; Pérez, C; Reis, J; Rodríguez-Franco, MI; Teixeira, J; Uriarte, E; Valencia, ME | 1 |
| Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J | 1 |
| Donnelly, CH; Murphy, DL; Richelson, E | 1 |
| Briley, M; Moret, C | 1 |
| Nag, M; Nandi, N | 1 |
| Aulakh, CS; Haass, M; Hill, JL; Murphy, DL; Wozniak, KM; Zohar, J | 1 |
| Aulakh, CS; Hill, JL; Murphy, DL; Wozniak, KM | 1 |
| Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
| Knoll, B; Knoll, J; Timar, J | 1 |
| Kane, JM; Lieberman, JA; Reife, R | 1 |
| Hauser, K; Häusler, A; Meeker, JB | 1 |
| Benedito, MA; Kafka, MS; Moore, RY; Naber, D; Wirz-Justice, A | 1 |
| Chadwick, A; Hall, TR; Harvey, S | 2 |
| Cohen, RM; Murphy, DL; Siever, LJ | 1 |
| Crawley, JN | 1 |
| Campbell, IC; Kafka, MS; Naber, D; O'Donohue, TL; Wehr, TA; Wirz-Justice, A | 1 |
| Campbell, IC; Wirz-Justice, A | 1 |
| Aulakh, CS; Hulihan-Giblin, BA; Park, YD | 1 |
| Aulakh, CS; Hill, JL; Lesch, KP; Murphy, DL; Tolliver, TJ; Wolozin, BL | 1 |
| Aulakh, CS; Hill, JL; Murphy, DL | 1 |
| Griffiths, HR; Lambert, DG; Lunec, J; Willets, JM | 1 |
| Artigas, F; Bel, N; Casanovas, JM; Romero, L | 1 |
| Richardson, G; Tate, B | 1 |
| Li, H; Meller, E; Shen, C | 1 |
| Cano, E; Fraiz, N; Orallo, F; Yáñez, M | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
3 review(s) available for imipramine and clorgyline
| Article | Year |
|---|---|
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries | 2020 |
Neuromuscular effects of monoamine oxidase inhibitors.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clomipramine; Clorgyline; Depressive Disorder; Female; Humans; Imipramine; Male; Middle Aged; Models, Biological; Monoamine Oxidase Inhibitors; Myoclonus; Neuromuscular Junction; Pargyline; Serotonin; Sleep, REM; Spasms, Infantile; Tranylcypromine; Trifluoperazine | 1986 |
Hormonal and pharmacological manipulation of the circadian clock: recent developments and future strategies.
Topics: Antidepressive Agents, Tricyclic; Antimanic Agents; Antioxidants; Circadian Rhythm; Clorgyline; Hormones; Humans; Hypothalamus; Imipramine; Lithium; Melatonin; Monoamine Oxidase Inhibitors | 2000 |
38 other study(ies) available for imipramine and clorgyline
| Article | Year |
|---|---|
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Synthesis, characterization, antidepressant and antioxidant activity of novel piperamides bearing piperidine and piperazine analogues.
Topics: Amides; Animals; Anti-Bacterial Agents; Antidepressive Agents; Antifungal Agents; Antioxidants; Behavior, Animal; Candida albicans; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperazine; Piperazines; Piperidines | 2012 |
Design, synthesis, and biological evaluation of oxindole derivatives as antidepressive agents.
Topics: Animals; Antidepressive Agents; Benzylidene Compounds; Clorgyline; Imipramine; Indoles; Lactams; Mice; Moclobemide; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2015 |
Synthesis and evaluation of 4-hydroxyl aurone derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Benzofurans; Blood-Brain Barrier; Chelating Agents; Copper; Humans; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Peptide Fragments; Protein Aggregates; Swine | 2016 |
Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors.
Topics: Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Structure-Activity Relationship | 2016 |
Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Isoflavones; Mannich Bases; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship | 2017 |
Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Cholinesterase Inhibitors; Drug Design; Electrophorus; Humans; Mannich Bases; Neuroprotective Agents; PC12 Cells; Rats | 2017 |
Design, synthesis and biological evaluation of 4'-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blood-Brain Barrier; Chalcones; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rivastigmine; Structure-Activity Relationship; Swine | 2017 |
DL-3-n-butylphthalide-Edaravone hybrids as novel dual inhibitors of amyloid-β aggregation and monoamine oxidases with high antioxidant potency for Alzheimer's therapy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipyrine; Benzofurans; Binding Sites; Blood-Brain Barrier; Edaravone; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Protein Structure, Tertiary | 2017 |
Multifunctional thioxanthone derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Cholinesterase Inhibitors; Humans; Kinetics; Models, Molecular; Monoamine Oxidase Inhibitors; Thioxanthenes; Xanthones | 2017 |
Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Electrophorus; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quinolines; Swine | 2017 |
Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Benzophenones; Binding Sites; Blood-Brain Barrier; Cell Survival; Cholinesterase Inhibitors; Drug Design; Humans; Hydrogen Peroxide; Inhibitory Concentration 50; Molecular Docking Simulation; Monoamine Oxidase; Neuroprotective Agents; PC12 Cells; Permeability; Phenols; Piperazines; Protein Structure, Tertiary; Rats; Structure-Activity Relationship | 2017 |
Design, synthesis and evaluation of 4'-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer's disease treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Cell Line; Cell Survival; Chalcones; Chelating Agents; Copper; Drug Design; Flurbiprofen; Humans; Lipopolysaccharides; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitric Oxide; Peptide Fragments; Recombinant Proteins; Structure-Activity Relationship | 2018 |
Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Benzylamines; Blood-Brain Barrier; Cholinesterase Inhibitors; Drug Design; Humans; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Permeability; Protein Aggregates; Recombinant Proteins; Structure-Activity Relationship; Thiazoles | 2018 |
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Topics: Alzheimer Disease; Blood-Brain Barrier; Cholinesterase Inhibitors; Cholinesterases; Chromones; Drug Design; Hep G2 Cells; Humans; Ligands; Molecular Docking Simulation; Molecular Targeted Therapy; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 2018 |
Substrate and inhibitor-related characteristics of monoamine oxidase in C6 rat glial cells.
Topics: Animals; Blood Platelets; Brain; Cell Line; Clorgyline; Humans; Imipramine; Kinetics; Male; Monoamine Oxidase; Neuroglia; Rats; Structure-Activity Relationship | 1976 |
Effect of antidepressant drugs on monoamine synthesis in brain in vivo.
Topics: Animals; Antidepressive Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Citalopram; Clorgyline; Cyclopropanes; Desipramine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Haloperidol; Hydrazines; Imipramine; Male; Milnacipran; Norepinephrine; Organ Specificity; Parietal Lobe; Rats; Rats, Wistar; Serotonin; Tyrosine 3-Monooxygenase | 1992 |
Antidepressants and brain respiration.
Topics: Amphetamine; Animals; Antidepressive Agents; Brain; Chlorides; Chlorpromazine; Clorgyline; Glucose; Imipramine; Lithium; Lithium Chloride; Male; Oxygen Consumption; Rats; Selegiline; Tranylcypromine | 1991 |
Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in rats.
Topics: Animals; Antidepressive Agents; Clorgyline; Corticosterone; Drug Interactions; Fenfluramine; Imipramine; Injections, Intravenous; Lithium; Male; Prolactin; Rats; Rats, Inbred Strains | 1991 |
Differential effects of long-term antidepressant treatments on 8-OHDPAT-induced increases in plasma prolactin and corticosterone in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Clomipramine; Clorgyline; Corticosterone; Imipramine; Male; Naphthalenes; Prolactin; Rats; Rats, Inbred Strains; Tetrahydronaphthalenes; Time Factors | 1988 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
Long-term administration of (-)deprenyl (selegiline), a compound which facilitates dopaminergic tone in the brain, leaves the sensitivity of dopamine receptors to apomorphine unchanged.
Topics: Animals; Apomorphine; Clorgyline; Dextroamphetamine; Drug Interactions; Female; Haloperidol; Imipramine; Male; Phenethylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Selegiline; Stereotyped Behavior | 1986 |
Effects of subchronic administration of psychoactive substances on the circadian rhythm of urinary corticosterone excretion in rats.
Topics: Animals; Antidepressive Agents; Circadian Rhythm; Clorgyline; Corticosterone; Fluoxetine; Imipramine; Male; Maprotiline; Pargyline; Propylamines; Rats; Trimipramine | 1985 |
Circadian rhythms in rat brain neurotransmitter receptors.
Topics: Animals; Circadian Rhythm; Clorgyline; Imipramine; Lithium; Male; Neurotransmitter Agents; Rats; Receptors, Cell Surface; Seasons; Sleep Deprivation | 1983 |
Relationship between hypothalamic serotoninergic activity and prolactin and growth hormone secretion in the domestic cockerel.
Topics: Animals; Brain; Clorgyline; Growth Hormone; Hydroxyindoleacetic Acid; Hypothalamus; Imipramine; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Poultry; Prolactin; Serotonin; Tryptophan | 1984 |
Mechanism of serotonin effects on prolactin and growth hormone secretion in domestic fowl.
Topics: alpha-Methyltyrosine; Animals; Brain; Chickens; Clorgyline; Fenclonine; Growth Hormone; Imipramine; Male; Methyltyrosines; Pargyline; Prolactin; Receptors, Serotonin; Selegiline; Serotonin; Tryptophan | 1983 |
Antidepressants and alpha 2-adrenergic autoreceptor desensitization.
Topics: Blood Pressure; Clonidine; Clorgyline; Drug Interactions; Female; Humans; Imipramine; Middle Aged; Propylamines; Receptors, Adrenergic; Receptors, Adrenergic, alpha | 1981 |
Preliminary report of a new rodent separation model of depression.
Topics: Animals; Brain; Clorgyline; Cricetinae; Depressive Disorder; Disease Models, Animal; Female; Humans; Imipramine; Male; Norepinephrine; Object Attachment; Serotonin | 1984 |
Effects of chronic lithium, clorgyline, imipramine, fluphenazine and constant darkness on the alpha-melanotropin content and circadian rhythm in rat brain.
Topics: Animals; Brain Chemistry; Circadian Rhythm; Clorgyline; Darkness; Fluphenazine; Imipramine; Lithium; Male; Melanocyte-Stimulating Hormones; Psychotropic Drugs; Rats; Rats, Inbred Strains | 1982 |
Antidepressant drugs can slow or dissociate circadian rhythms.
Topics: Activity Cycles; Animals; Brain; Circadian Rhythm; Clorgyline; Cricetinae; Female; Imipramine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Propylamines | 1982 |
Differential effects of chronic antidepressant treatment on 5-HT1C receptor binding sites in Wistar rat brain.
Topics: Animals; Brain; Clomipramine; Clorgyline; Ergolines; Imipramine; Male; Rats; Rats, Wistar; Receptors, Serotonin | 1994 |
Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants.
Topics: Animals; Base Sequence; Brain Chemistry; Carrier Proteins; Clorgyline; Fluoxetine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Molecular Sequence Data; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Piperazines; Raphe Nuclei; Rats; Rats, Wistar; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Antidepressive Agents; Clomipramine; Clorgyline; Corticosterone; Imipramine; Male; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Species Specificity | 1993 |
Studies on the neurotoxicity of 6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in SH-SY5Y cells.
Topics: Adenylyl Cyclases; Adrenergic Uptake Inhibitors; Catecholamines; Cell Death; Clorgyline; Dose-Response Relationship, Drug; Guanylate Cyclase; Humans; Imipramine; Indoles; Isoquinolines; L-Lactate Dehydrogenase; Monoamine Oxidase Inhibitors; Neuroblastoma; Neurotoxins; Nitroprusside; Receptors, Muscarinic; Selegiline; Tumor Cells, Cultured | 1995 |
Adaptative changes of the serotonergic system after antidepressant treatments.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Clomipramine; Clorgyline; Fluvoxamine; Frontal Lobe; Hydroxyindoleacetic Acid; Imipramine; Microdialysis; Monoamine Oxidase Inhibitors; Piperidines; Pyrimidines; Raphe Nuclei; Rats; Serotonin; Stereotaxic Techniques; Tranylcypromine; Tryptophan | 1996 |
Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Clorgyline; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Imipramine; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Sulfur Radioisotopes | 2002 |
(-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
Topics: Animals; Benzofurans; Blood Platelets; Brain; Cell Line; Citalopram; Clorgyline; Dose-Response Relationship, Drug; Fluoxetine; Humans; Imipramine; Iproniazid; Isoenzymes; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Selegiline; Serotonin; Stilbenes; Synaptosomes; Tritium; Wine | 2006 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |